About Us
Our Leadership
Our leadership team are determined to reshape the UK’s medicines discovery industry.
They specialise in driving scientific innovation, new technologies and encouraging collaboration. They understand the challenges facing medicine discovery and the needs of big pharma, academia, leading technology providers, SMEs, charities and start-ups.


Professor Chris Molloy
Chief Executive Officer

Dr Nicola Heron
Chief Strategy Officer

Clare Atherton
Chief People Officer

Sinéad McCormack
Chief Financial Officer

Robert Sherville-Payne
General Counsel and Company Secretary

Dr Martin Main
Chief Scientific Officer
